Clinical Trials Browser

Unknown × OTHER × Mesothelioma, Malignant × Clear all

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT04823741 2024-02-01

SCITH-MESO

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05910112 2023-06-18

PROSPECT

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Pneumothorax, Pleural Effusion, Malignant

NCT03654833 2023-03-14

MiST

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05508555 2022-08-22

Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma

Phase NA Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05077111 2021-10-14

VATS

Phase 4 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pulmonary Atelectasis, Hemothorax, Lung Diseases, Pericardial Effusion, Pleural Diseases, Pleural Neoplasms, Pneumothorax, Pleural Effusion, Malignant, Empyema, Pleural, Respiratory Aspiration

NCT04713761 2021-01-26

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03210298 2019-10-08

PIPACRegis

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Appendiceal Neoplasms, Ascites, Gallbladder Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Pleural Effusion, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT03558932 2018-06-15

IP3R Modulation by Cancer Genes in Mesothelioma

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02761863 2018-02-23

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT03290183 2017-09-21

Confocal Laser Endomicroscopy in Pleural Malignancies

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Diseases, Thymoma

NCT02755675 2016-11-21

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT02588131 2015-10-27

A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02580747 2015-10-20

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Phase 1 Unknown

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Ovarian Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT02497053 2015-07-14

Four Versus Six Cycles of Pemetrexed/Platinum for MPM

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01279967 2014-11-20

ADAM

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01655888 2012-08-02

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01649024 2012-07-25

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01343264 2011-04-28

Trimodality Therapy for Malignant Pleural Mesothelioma

Other solid neoplasmThoracic

Mesothelioma, Malignant